HPV & Related Diseases

Human papillomavirus (HPV) infections cause more than 35,900 cancers annually in the United States. HPV is responsible for a large percentage of female cancers – cervical (99%), vaginal (75%), and vulvar (69%) – and women are disproportionately affected by HPV-related anal (66%) and oropharyngeal (70%) cancers. Studies report that the United States lags behind other developed countries when it comes to HPV vaccination uptake as well as cervical cancer incidence rates. While cervical cancer incidence and mortality rates have declined significantly in the United States over the last 50 years, there is a pressing public health need for cancer prevention through HPV vaccination, screening and early diagnosis, and treatment of precancerous disease.

HPV & Related Diseases are part of the SWHR Infectious Diseases Network, which engages the following focus areas: HPV & Related Diseases and Vaccines.

Program Goals

  • Review the state of the science for HPV-related diseases in women, with special emphasis on anogenital and oropharyngeal cancers
  • Identify knowledge gaps and opportunities for innovation in research, clinical practice, and patient education concerning preventive care and treatments for HPV-related diseases
  • Develop recommendations and educational materials to increase awareness, address gaps, and improve health outcomes for women at risk for HPV-related diseases

Facts about HPV & Related Diseases

85%

of people in the United States will get an HPV infection in their lifetime

~21,500

HPV-related cancer cases occur in women each year

97%

of cervical cancers can be prevented by the HPV vaccine if taken before exposure to the virus

More about HPV & Related Diseases